TED.F · TerrAscend Corp

-

Please sign in to comment on TED.F

1 Comment

Admin

4 years, 1 month ago

TerrAscend Corp is currently in a long term uptrend where the price is trading 0.5% above its 200 day moving average.

From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.7.

TerrAscend Corp's total revenue rose by 152.4% to $65M since the same quarter in the previous year.

Its net income has increased by 33.8% to $-112M since the same quarter in the previous year.

Finally, its free cash flow grew by 120.0% to $5M since the same quarter in the previous year.

Based on the above factors, TerrAscend Corp gets an overall score of 5/5.

Exchange	F
CurrencyCode	EUR
ISIN	CA88105E1088
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare

Beta	2.21
Market Cap	111M
Target Price	None
PE Ratio	0.0
Dividend Yield	None

ABOUT

TerrAscend Corp

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States. The company manufactures vaporizables, concentrates, topicals, flowers, tinctures, and edibles. It offers its products under the brand name Kind Tree Cannabis, GAGE Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, Cookies, and Lemonnade. The company also operates retail dispensaries under the Apothecarium, TerrAscend, Pinnacle Emporium, GAGE Cannabis, and State Flower brand names. It serves medical patients and adult-use consumers in North America. The company was incorporated in 2017 and is headquartered in King Of Prussia, Pennsylvania.

TED.F · TerrAscend Corp

-

TerrAscend Corp

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest TerrAscend Corp using a moving average strategy